MCID: SCH014
MIFTS: 58

Schistosomiasis malady

Categories: Rare diseases, Infectious diseases, Blood diseases

Aliases & Classifications for Schistosomiasis

About this section

Summaries for Schistosomiasis

About this section
NIH Rare Diseases:48 Schistosomiasis is a disease caused by parasitic worms. although the worms that cause schistosomiasis are not found in the united states, more than 200 million people are infected worldwide. infection occurs through contact with contaminated water. the parasite in its infective stages is called a cercaria. it swims freely in open bodies of water. on contact with humans, the parasite burrows into the skin, matures into another stage (schistosomula), then migrates to the lungs and liver, where it matures into the adult form. the adult worm then migrates to its preferred body part (bladder, rectum, intestines, liver, portal venous system (the veins that carry blood from the intestines to liver, spleen, lungs), depending on its species.  schistosomiasis is common in many tropical and subtropical areas worldwide. it can be treated safely and effectively with praziquantel. last updated: 3/15/2013

MalaCards based summary: Schistosomiasis, also known as katayama fever, is related to hepatitis and abdominal tuberculosis. An important gene associated with Schistosomiasis is IL4 (Interleukin 4), and among its related pathways are IL-9 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types and African trypanosomiasis. The drugs praziquantel and oxamniquine have been mentioned in the context of this disorder. Affiliated tissues include liver, skin and spleen, and related mouse phenotypes are integument and renal/urinary system.

Disease Ontology:11 A parasitic helminthiasis infectious disease that involves infection of the intestine, urinary tract, skin, liver and spleen caused by multiple species of the trematode fluke of the genus Schistosoma. The symptoms include fever, chills, nausea, abdominal pain, diarrhea, malaise, myalgia, liver and spleen enlargement, rash and hematuria.

CDC:2 Schistosomiasis, also known as bilharzia, is a disease caused by parasitic worms. Although the worms that cause schistosomiasis are not found in the United States, more than 200 million people are infected worldwide. In terms of impact this disease is second only to malaria as the most devastating parasitic disease. Schistosomiasis is considered one of the Neglected Tropical Diseases (NTDs).

Wikipedia:71 Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms... more...

Related Diseases for Schistosomiasis

About this section

Diseases related to Schistosomiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 469)
idRelated DiseaseScoreTop Affiliating Genes
1hepatitis30.3IFNG, IL10, IL2, TNF
2abdominal tuberculosis29.5CD40LG, CD79A, IL10
3loiasis29.4CD79A, IFNG, IL10, IL13, IL4, IL5
4tuberculosis29.4CD40LG, IL10, IL2, IL4, TNF
5chronic thromboembolic pulmonary hypertension29.2IFNG, IL10, IL2
6pulmonary tuberculosis28.8CD40LG, IFNG, IGHE, IL10, IL13, IL4
7intestinal schistosomiasis12.4
8urinary schistosomiasis12.3
9cercarial dermatitis11.8
10schistosoma mansoni infection, susceptibility/11.3
11neuroschistosomiasis10.9
12myoglobinuria recurrent10.4IFNG, IL4
13esophageal cancer, childhood10.4CD40LG, IGHE
14dahlberg borer newcomer syndrome10.3IL13, IL5
15lymphoblastic leukemia10.3IL13, IL4, IL5
16lactose intolerance10.3IL13, IL4, IL5
17renal hypertension10.3IL13, IL5, RNASE3
18lymphocytic gastritis10.3IL13, IL4, IL5
19papillary squamous carcinoma10.3IGHE, IL4, IL5
20marasmus10.3IL4, IL5, RNASE3
21duodenal somatostatinoma10.3IL13, IL4, IL5
22alcoholic neuropathy10.3CD40LG, CD79A
23lens-induced iridocyclitis10.3IL4, IL5, RNASE3
24camptodactyly vertebral fusion10.3CD40LG, CD79A
25israeli tick typhus10.3CD40LG, IFNG, IL13
26cutaneous fibrous histiocytoma10.3IFNG, IL4, IL5
27pyridoxal 5'-phosphate-dependent epilepsy10.3IL10, TNF
28cerebral primitive neuroectodermal tumor10.3IL4, IL5, RNASE3
29disordered steroidogenesis due to cytochrome p450 oxidoreductase10.3IL13, IL5, STAT6
30aortic atherosclerosis10.3IL13, IL5, TNF
31asymptomatic neurosyphilis10.3IFNG, IL10, IL4
32childhood malignant mesenchymoma10.3IL13, IL5, RNASE3
33hyperinsulinism due to glutamodehydrogenase deficiency10.3IFNG, IGHE, IL4
34tungiasis10.3IFNG, IL10, IL4
35central gyrate choroidal dystrophy10.3CD40LG, IGHE, RNASE3
36maturity-onset diabetes of the young10.3CD40LG, IL10
37stocco dos santos syndrome10.3IFNG, IGHE, TNF
38multiple mitochondrial dysfunctions syndrome10.3IFNG, IL10, IL5
39hypotrichosis 410.3IFNG, IL4, TNF
40spinal polio10.3CD40LG, CD79A
41tubular renal disease-cardiomyopathy syndrome10.3IL10, IL4, TNF
42rabies10.3CD40LG, CD79A
43unilateral retinoblastoma10.3CD40LG, CD79A
44congenital dyserythropoietic anemia10.3ALB, TNF
45mesangial proliferative glomerulonephritis10.3CD40LG, CD79A
46lagophthalmos10.3IL10, IL4, TNF
47tarsal tunnel syndrome10.3IL10, IL13, TNF
48conidiobolomycosis10.3IL10, IL4, TNF
49bile duct signet ring cell carcinoma10.3IL5, RNASE3, TNF
50indomethacin antenatal infection10.3CD40LG, CD79A, IGHE

Graphical network of the top 20 diseases related to Schistosomiasis:



Diseases related to schistosomiasis

Symptoms & Phenotypes for Schistosomiasis

About this section

MGI Mouse Phenotypes related to Schistosomiasis according to GeneCards Suite gene sharing:

41 (show all 13)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107718.8CD40LG, F2, IFNG, IFNGR1, IL10, IL13
2MP:00053678.7ALB, CD40LG, CD79A, IFNG, IFNGR1, IL4
3MP:00053888.7F2, IFNG, IL10, IL13, IL2, IL4
4MP:00020068.7ALB, CD79A, IFNG, IFNGR1, IL10, IL2
5MP:00053798.6ALB, CD40LG, IFNG, IFNGR1, IL10, IL13
6MP:00053818.6ALB, F2, IFNG, IFNGR1, IL10, IL13
7MP:00053898.2CD40LG, F2, IFNG, IFNGR1, IL10, IL13
8MP:00053907.8CD40LG, F2, IFNG, IFNGR1, IL10, IL13
9MP:00053847.7ALB, CD40LG, CD79A, IFNG, IFNGR1, IL10
10MP:00053707.4ALB, ARG1, CD79A, IFNG, IFNGR1, IL10
11MP:00053976.9ARG1, CD40LG, CD79A, F2, IFNG, IFNGR1
12MP:00053876.9ARG1, CD40LG, CD79A, F2, IFNG, IFNGR1
13MP:00053766.2ALB, ARG1, CD40LG, CD79A, F2, IFNG

Drugs & Therapeutics for Schistosomiasis

About this section

Drugs for Schistosomiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 76)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Miconazoleapproved, investigational, vet_approvedPhase 4370622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
2
Praziquantelapproved, vet_approvedPhase 4, Phase 3, Phase 2, Phase 13955268-74-14891
Synonyms:
(.+-)-2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1a)isoquinolin-4-one
(11bS)-2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one
135526-78-2
2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro- 4H-pyrazino[2,1-a]-isoquinolin-4-one
2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1-a)isoquinolin-4-one
2-(Cyclohexylcarbonyl)-1,2,3,6,7-11b-hexahydro-4H-pyrazino(2,1a)isoquinolin-4-one
2-(Cyclohexylcarbonyl)-1,2,3,6,7-11b-hexahydro-4H-pyrazinoe(2,1a)isoquinolin-4-one
2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one
2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one
2-Cyclohexanecarbonyl-1,2,3,6,7,11b-hexahydro-pyrazino[2,1-a]isoquinolin-4-one
2-Cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1-a) isoquinolin-4-one
46648_FLUKA
46648_RIEDEL
5-24-03-00361 (Beilstein Handbook Reference)
55268-74-1
57452-31-0
8440, EMBAY
AB00052075
AC-11670
AC1L1J6N
AKOS000541869
Azinox
BAS 00347357
BPBio1_000088
BRD-A21858158-001-05-2
BRN 0761557
BSPBio_000080
BSPBio_002199
Bay-8440
Bayer Brand of Praziquantel
Biliricide
Biltricide
Biltricide (TN)
Biltricide, Droncit, Praziquantel
Bio-0456
C07367
CCRIS 4114
CHEMBL976
CID4891
CPD000037139
Cesol
Cisticid
Cutter
Cutter Tape Tabs
Cysticide
D00471
D011223
DB01058
DivK1c_000130
Droncit
Drontsit
EINECS 259-559-6
EINECS 260-741-2
EMBAY-8440
EU-0100909
Embay 8440
HMS1568D22
HMS1920J06
HMS2090J19
 
HMS2092A09
HMS500G12
I06-0088
IDI1_000130
InChI=1/C19H24N2O2/c22-18-13-20(19(23)15-7-2-1-3-8-15)12-17-16-9-5-4-6-14(16)10-11-21(17)18/h4-6,9,15,17H,1-3,7-8,10-13H
KBio1_000130
KBio2_001599
KBio2_004167
KBio2_006735
KBio3_001699
KBioGR_000963
KBioSS_001599
LS-23174
LS-7155
Lopac0_000909
MLS000028528
MLS000038419
MLS001201812
MLS001304085
Merck Brand of Praziquantel
MolPort-001-926-470
NCGC00015818-05
NCGC00015818-11
NCGC00089733-02
NCGC00089733-03
NCGC00089733-04
NCGC00089733-05
NINDS_000130
NPFAPI-02
Oprea1_163497
P 4668
P4668_SIGMA
Prasiquantel
Praziquantel (JAN/USP/INN)
Praziquantel [USAN:INN:BAN:JAN]
Praziquantel, (+-)-Isomer
Praziquantel, (R)-Isomer
Praziquantel, (S)-Isomer
Praziquantelum
Praziquantelum [INN-Latin]
Prestwick0_000260
Prestwick1_000260
Prestwick2_000260
Prestwick3_000260
Prestwick_402
Pyquiton
S1691_Selleck
SAM002264632
SMR000037139
SPBio_001295
SPBio_002299
SPECTRUM1500494
STK030186
Spectrum2_001288
Spectrum3_000550
Spectrum4_000482
Spectrum5_001064
Spectrum_001119
Traziquantel
UNII-6490C9U457
praziquantel
3
Albendazoleapproved, vet_approvedPhase 4, Phase 38554965-21-82082
Synonyms:
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8
A4673_FLUKA
A4673_SIGMA
AB00052377
AC-015
AC1L1CVL
AC1Q2YKD
AKOS000540882
Albendazol
Albendazol [INN-Spanish]
Albendazole
Albendazole (JAN/USP/INN)
Albendazole Armstrong Brand
Albendazole Diba Brand
Albendazole Fustery Brand
Albendazole Hormona Brand
Albendazole Liferpal Brand
Albendazole Monohydrochloride
Albendazole Noe-Socopharm Brand
Albendazole Pfizer Brand
Albendazole Sanicoopa Brand
Albendazole Valdecasas Brand
Albendazole [USAN:INN:BAN:JAN]
Albendazolum
Albendazolum [INN-Latin]
Albendoral
Albenza
Albenza (TN)
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong Brand of Albendazole
BAS 00439961
BB_SC-1386
BIDD:GT0615
BIM-0051849.0001
BPBio1_000038
BRD-K79131256-001-04-7
BSPBio_000034
BSPBio_002548
Bendapar
Bilutac
C01779
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
CAS-54965-21-8
CHEBI:16664
CHEBI:506787
CHEMBL1483
CID2082
CPD000036735
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
ChemDiv1_000190
ChemDivAM_000003
D00134
D015766
DB00518
Diba Brand of Albendazole
Digezanol
Disthelm
Disthelm, Mediamix V
DivK1c_000704
EINECS 259-414-7
Endoplus
Eskazole
Fustery Brand of Albendazole
Gascop
HMS1568B16
HMS1922K04
HMS2090G19
HMS2093K13
HMS502D06
HMS587I14
HSDB 7444
Hormona Brand of Albendazole
I01-0380
IDI1_000704
InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
KBio1_000704
 
KBio2_002012
KBio2_004580
KBio2_007148
KBioGR_000801
KBioSS_002012
LS-50618
Liferpal Brand of Albendazole
Lurdex
MLS000069722
Mediamix V Disthelm
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Metiazol
MolPort-000-726-929
MolPort-000-760-571
MolPort-001-932-918
Monohydrochloride, Albendazole
NCGC00016876-01
NCGC00016876-02
NCGC00022896-03
NCGC00022896-04
NCGC00022896-05
NCGC00022896-06
NCGC00022896-07
NINDS_000704
NSC 220008
NSC220008
Noe Socopharm Brand of Albendazole
Noe-Socopharm Brand of Albendazole
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
Oprea1_429292
Oprea1_585016
Oprea1_640007
Pfizer Brand of Albendazole
Prestwick0_000247
Prestwick1_000247
Prestwick2_000247
Prestwick3_000247
Prestwick_675
Proftril
Ricobendazole
Rycobendazole
S1640_Selleck
SAM002589939
SK&F 62979
SK&F-62979
SK&F62979
SKF 62979
SKF-62979
SKF62979
SMR000036735
SPBio_002253
SPECTRUM1503903
STK387550
STL046130
STOCK2S-67946
Sanicoopa Brand of Albendazole
Smith Kline & French Brand of Albendazole
SmithKline Beecham Brand of Albendazole
Spectrum4_000201
Spectrum5_001567
Spectrum_001532
TL8003543
UNII-F4216019LN
V Disthelm, Mediamix
VU0239747-6
Valbazen
Valdecasas Brand of Albendazole
ZINC17146904
Zental
Zentel
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
albendazole
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
4
LumefantrineapprovedPhase 414882186-77-46437380
Synonyms:
(+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-alpha((dibutylamino)methyl)fluorene-4-methanol
(+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-alpha-((dibutylamino)methyl)fluorene-4-methanol
(±)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-α-((dibutylamino)methyl)fluorene-4-methanol
120583-69-9
2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl]ethanol
2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]fluoren-4-yl]ethanol
2-Dibutylamino-1-[2,7-dichloro-9-(4-chloro-benzylidene)-9H-fluoren-4-yl]-ethanol
2-Dibutylamino-1-{2,7-dichloro-9-[1-(4-chloro-phenyl)-meth-(Z)-ylidene]-9H-fluoren-4-yl}-ethanol
82186-77-4
AC-4542
AC1O5NKD
Benflumetol
Bio-0132
C30H32Cl3NO
 
CHEBI:156095
CHEMBL38827
CID6437380
Coartem
D03821
DB06708
HSDB 7210
I14-7746
LS-177674
Lumefantrine
Lumefantrine (INN)
Lumefantrine [INN:BAN]
MolPort-006-394-826
NCGC00167490-01
UNII-F38R0JR742
dl-Benflumelol
5
ArtemetherapprovedPhase 415071963-77-4119380, 68911
Synonyms:
( )-alpha-Artemether
(1R,4S,5R,8S,9R,10S,12R,13R)-10-Methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecane
(3R,5aS,6R,8aS,9R,10S,12R,12aR)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepine
(3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin
(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12beta,12aR*)-isomer of artemether
(3r,5as,6r,8as,9r,10r,12r,12ar)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromene
(5aS,6R,8aS,9R,10S,12R,12aR)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromene
.beta.-Artemether
.beta.-Dihydroartemisinin methyl ether
.beta.-Methylether of 11-epi-dihydroartemisinin
10-Methoxy-1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane
10-methoxy-1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane
159573-83-8
3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin, decahydro-10-methoxy-3,6,9-tri
71939-51-0
71963-77-4
74784-06-8
80286-56-2
93787-85-0
AC1L2APD
AC1L2XO8
AC1L9SH2
AC1L9UV0
AC1MI2ZX
AC1Q6Z74
AC1Q6Z7V
AR-1A4424
Arteannuin ether
Artemetero
Artemetero [INN-Spanish]
Artemether
Artemether (INN)
Artemether [INN]
Artemetheri
Artemetherum
Artemetherum [INN-Latin]
Artemisininelactol methyl ether
Artemos
Artenam
Artesaph
Artesian
Artimist
Artmether
BRN 5948416
C16H26O5
CHEBI:195280
 
CHEMBL411864
CHEMBL512315
CID10266705
CID104888
CID3062122
CID456408
CID500199
CID6483308
CID6712286
CID68911
CID9796294
CID9796295
CPD000469218
D02483
DB06697
Dihydroartemisinin methyl ether
Dihydroqinghaosu methyl ether
Dihydroquinghaosu methyl ether
Falcidol
Gvither
HMS2052L09
HSDB 7456
I06-0205
KST-1A8041
LS-176935
LS-64237
MLS001424249
Malartem
Methyl-dihydroartemisinine
NCI60_022891
NSC 665970
NSC665970
O-Methyldihydroartemisinine
Paluther
S2264_Selleck
SAM001246799
SM 224
SM 229
SM-224
SMR000469218
UNII-C7D6T3H22J
alpha-Artemether
alpha-Dihydroartemisinin methyl ether
artemether, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,12aR*))-isomer
artemether[inn]
beta-Artemether
beta-Dihydroartemisinin methyl ether
rither
6AntimalarialsPhase 4, Phase 2, Phase 31246
7Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 122062
8Antifungal AgentsPhase 43696
9AnthelminticsPhase 4, Phase 3, Phase 2, Phase 1446
10ArtemisininsPhase 4, Phase 2, Phase 3289
11ArtemisininePhase 4, Phase 2, Phase 3289
12Antiparasitic AgentsPhase 4, Phase 3, Phase 2, Phase 12199
13Antiprotozoal AgentsPhase 4, Phase 2, Phase 32051
14Antimitotic AgentsPhase 4, Phase 35657
15Artemether-lumefantrine combinationPhase 4141
16
SulfadoxineapprovedPhase 3, Phase 21322447-57-617134
Synonyms:
2447-57-6
4-Amino-N-(5,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide
4-Sulfanilamido-5,6-dimethoxypyrimidine
4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide
4-amino-N-[5,6-bis(methyloxy)pyrimidin-4-yl]benzenesulfonamide
46810_RIEDEL
5-25-13-00306 (Beilstein Handbook Reference)
6-(4-Aminobenzenesulfonamido)-4,5-dimethoxypyrimidine
AB00514044
AC-11921
AC1L29DT
AC1Q46GG
Ambap2447-57-6
BPBio1_001286
BRD-K55250441-001-03-1
BRN 0625453
BSPBio_001168
C07630
CAS-2447-57-6
CHEBI:9329
CHEMBL1539
CID17134
D00580
DB01299
EINECS 219-504-9
Fanasil
Fanzil
HMS1571K10
HMS2090P07
HMS2094C19
I09-0529
LS-31247
MLS002154150
MolPort-003-850-341
N'-(5,6-Dimethoxy-4-pyrimidyl)sulfanilamide
N(sup 1)-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide
 
N1-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide
NCGC00016612-01
NCGC00016612-02
Orthosulfin
Prestwick0_001094
Prestwick1_001094
Prestwick2_001094
Prestwick3_001094
Ro 4-4393
Ro-4-4393
S2511_Selleck
S7821_SIGMA
SMR000857259
SPBio_003054
SULFADOXINE
Sanasil: Sulfadoxine: Sulformetoxin
Solfadossina
Solfadossina [DCIT]
Sulfadoxin
Sulfadoxina
Sulfadoxina [INN-Spanish]
Sulfadoxine
Sulfadoxine (JAN/USP/INN)
Sulfadoxine [USAN:INN:BAN:JAN]
Sulfadoxinum
Sulfadoxinum [INN-Latin]
Sulformethoxine
Sulformetoxine
Sulforthomidine
Sulphadoxine
Sulphormethoxine
Sulphormetoxin
Sulphorthodimethoxine
UNII-88463U4SM5
WR 4073
WR 4873
ZINC00002094
17
Pyrimethamineapproved, vet_approvedPhase 2, Phase 315758-14-04993
Synonyms:
2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine
46706_FLUKA
46706_RIEDEL
4753 R.P.
4753 r.p
5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine
5-(4-CHLORO-PHENYL)-6-ETHYL-PYRIMIDINE-2,4-DIAMINE
5-(4-CHLOROPHENYL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE
5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidi nediamine
5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine
5-(4-chlorophenyl)-2,4-diamino-6-ethylpyrimidine
5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine
5-(p-chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
5-[4-Chlorophenyl]-6-ethyl-2,4-pyrimidinediamine
58-14-0
AB00052084
AC-7879
AC1L1JDI
AI3-25005
AZT + Pyrimethamine combination
Aventis Brand of Pyrimethamine
BIDD:GT0149
BIDD:PXR0173
BPBio1_000147
BRD-K88429204-001-05-4
BRN 0219864
BSPBio_000133
BSPBio_003282
BW 50-63
BW 5063
C07391
C12H13ClN4
CAS-58-14-0
CCRIS 546
CD
CHEBI:8673
CHEMBL36
CID4993
CP6
CPD000058714
CRL-8131 & Pyrimethamine
CRL-8142 & Pyrimethamine
Chloridin
Chloridine
Chloridyn
D00488
D011739
DB00205
Darachlor
Daraclor
Darapram
Daraprim
Daraprim (TN)
Daraprime
Daraprin
Diaminopyritamin
Disulone
DivK1c_000652
EINECS 200-364-2
EXR-101
Erbaprelina
Ethylpyrimidine
Fansidar
Fansidar (Pyrimethamine/Sulfadoxine)
Glaxo Wellcome Brand of Pyrimethamine
GlaxoSmithKline Brand of Pyrimethamine
HMS1568G15
HMS1920N12
HMS2092E13
HMS502A14
IDI1_000652
KBio1_000652
KBio2_001386
KBio2_003954
 
KBio2_006522
KBio3_002502
KBioGR_001007
KBioSS_001386
Khloridin
L000713
LS-238
Lactoferrin B & Pyrimethamine
Lactoferrin H & Pyrimethamine
MCB-3837
MLS000028606
MLS001148621
MLS002454446
MLS002701881
Malacid
Malocid
Malocide
Maloprim
MolPort-001-783-655
NCGC00016256-01
NCGC00016256-02
NCGC00023188-03
NCGC00023188-04
NCGC00023188-05
NCGC00023188-06
NCGC00023188-07
NCI-C01683
NCI60_002604
NCIOpen2_008313
NINDS_000652
NSC 3061
NSC-3061
NSC3061
Oxaquin
Pirimecidan
Pirimetamin
Pirimetamina
Pirimetamina [INN-Spanish]
Pirimetamina [Spanish]
Prestwick0_000037
Prestwick1_000037
Prestwick2_000037
Prestwick3_000037
Prestwick_504
Primethamine
Pyremethamine
Pyrimethamin
Pyrimethamine (JAN/USP/INN)
Pyrimethamine (Pyr)
Pyrimethamine Hcl
Pyrimethamine [USAN:INN:BAN:JAN]
Pyrimethaminum
Pyrimethaminum [INN-Latin]
RP 4753
S2006_Selleck
SAM002554921
SMR000058714
SPBio_000672
SPBio_002054
SPECTRUM1500520
Spectrum2_000886
Spectrum3_001701
Spectrum4_000494
Spectrum5_001447
Spectrum_000906
TCMDC-123831
TCMDC-125860
Tindurin
Tindurine
Tinduring
UNII-Z3614QOX8W
WLN: T6N CNJ BZ DZ ER DG& F2
WR 2978
Wellcome Brand of Pyrimethamine
ZINC00057464
m alocid
nchembio.215-comp13
nchembio.87-comp22
pyrimethamine
18
IronapprovedPhase 311657439-89-623925
Synonyms:
02583_FLUKA
12310_ALDRICH
12310_RIEDEL
129048-51-7
14067-02-8
161135-39-3
190454-13-8
195161-83-2
199281-22-6
209309_ALDRICH
209309_SIAL
255637_ALDRICH
266213_ALDRICH
266256_ALDRICH
267945_ALDRICH
267953_ALDRICH
26Fe
338141_ALDRICH
356808_ALDRICH
356824_ALDRICH
356832_ALDRICH
39344-71-3
3ZhP
413054_ALDRICH
443783-52-6
44890_ALDRICH
44890_FLUKA
675141-17-0
70884-35-4
73135-38-3
7439-89-6
8011-79-8
8053-60-9
AC1L2N38
ATW 230
ATW 432
Ancor B
Ancor en 80/150
Armco iron
Atomel 28
Atomel 300M200
Atomel 500M
Atomel 95
Atomiron 44MR
Atomiron 5M
Atomiron AFP 25
Atomiron AFP 5
C00023
C3518_SIAL
C3518_SIGMA
CCRIS 1580
CHEBI:18248
CID23925
Carbonyl iron
Copy Powder CS 105-175
D007501
DB01592
DSP 1000
DSP 128B
DSP 135
DSP 135C
DSP 138
Diseases (animal), iron overload
Diseases, iron overload
EF 1000
EF 250
EFV 200/300
EFV 250
EFV 250/400
EINECS 231-096-4
 
Ed-In-Sol
Eisen
Electrolytic iron
F 60 (metal)
FE
FT 3 (element)
Fe
Fe-40
Fe1+
Feronate
Ferretts
Ferro-Caps
Ferro-Time
Ferrousal
Ferrovac E
Ferrum
Ferrum metallicum
GS 6
HF 2 (element)
HL (iron)
HQ (metal)
HS (iron)
HS 4849
HSDB 604
Hemocyte
Hierro
Hoeganaes ATW 230
Hoeganaes EH
IRMM524A_FLUKA
IRMM524B_FLUKA
IRON
Iron (Fe)
Iron (Fe1+)
Iron ion (Fe+)
Iron ion(1+)
Iron monocation
Iron powder
Iron standard for AAS
Iron(1+)
Iron(1+) ion
Iron(III) nitrate solution
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (Fe1+)
Iron, ion (Fe1+) (8CI,9CI)
Iron, reduced
LOHA
LS-3196
MolPort-003-925-001
NC 100
PZh-1M3
PZh-2
PZh1M1
PZh2M
PZh2M1
PZh2M2
PZh3
PZh3M
PZh4M
PZhO
Reduced iron
Remko
SUY-B 2
Siderol
UNII-E1UOL152H7
Vitedyn-Slo
Yieronia
fer
ferrous iron
hierro
19
ArtesunateapprovedPhase 2, Phase 318588495-63-06917864, 5464098
Synonyms:
(3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-ol, hydrogen succinate
112346-66-4
182824-33-5
252637-87-9
4-Oxo-4-(((3R,5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxypyrano(4,3-j)-1,2-benzodioxepin-10-yl hydrogen butanedioate
4-oxo-4-{[(3r,5as,6r,8as,9r,10r,12r,12ar)-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl]oxy}butanoic acid
4-oxo-4-{[(5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl]oxy}butanoic acid
83507-69-1
88495-63-0
91487-94-4
AC1L23PW
AC1L2XWW
AC1L4FU0
AC1Q5VRV
AKOS004119951
AS
Ambap88495-63-0
Arinate
Arsumax
Arsumax (TN)
Artesunate
Artesunate (USAN)
Artesunate (superseded RN)
Artesunato
Artesunato [INN-Spanish]
Artesunatum
Artesunatum [INN-Latin]
Artesunic acid
Artsuna
BB_NC-1045
Butanedioic acid, mono((3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-yl) ester
Butanedioic acid, mono(decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-yl) ester
C19H28O8
CHEMBL218601
CHEMBL258608
CID105031
CID11520210
CID11988384
CID156252
 
CID5464098
CID65664
CID6917864
CID9821433
CPD000466336
D02482
Dihydroartemisinine-12-alpha-succinate
Dihydroqinghaosusuccinate
Dihydroqinghasu hemsuccinate
FT-0082543
HMS2051I14
HMS2090L16
HSDB 7458
I06-0204
LS-177760
LS-187735
MLS000759445
MLS001424053
MolPort-001-732-325
MolPort-006-392-384
NCI60_039350
NSC712571
Nuartez
Plasmotrim
Plasmotrin
Qinghaozhi
Quinghaosu reduced succinate ester
S2265_Selleck
SAM001246628
SM 804
SMR000466336
STK801911
Succinyl dihydroartemisinin
UNII-60W3249T9M
WR 256283
WR-256283
artesunato
artesunatum
artesunic acid
butanedioic acid, 1-[(3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-yl] ester
dihydroqinghasu hemsuccinate
20
Tranexamic AcidapprovedPhase 32771197-18-85526
Synonyms:
08455_FLUKA
1197-17-7
1197-18-8
1ceb
3-14-00-00868 (Beilstein Handbook Reference)
4-(Aminomethyl)-Cyclohexanecarboxylic Acid
4-(Aminomethyl)cyclohexanecarboxylic acid
4-(aminomethyl)cyclohexane-1-carboxylic acid
857653_ALDRICH
A0236
AB00052260
AB1003647
AC-4687
AC1L1KJH
AC1Q50F3
AC1Q546D
AC1Q5U04
ALBB-006013
AMCA
AMCHA
AMH
AR-1F6595
Acide tranexamique
Acide tranexamique [INN-French]
Acido tranexamico
Acido tranexamico [INN-Spanish]
Acidum tranexamicum
Acidum tranexamicum [INN-Latin]
Amikapron
Amstat
Anvitoff
BAY 3517
BPBio1_000069
BRN 2207452
BSPBio_000061
BSPBio_002837
CAS-1197-18-8
CHEBI:48669
CHEMBL292500
CHEMBL877
CID5526
CL 65336
CL-65336
Carxamin
Cyclocapron
Cyklokapron
Cyklokapron (TN)
D01136
DB00302
DV 79
DV-79
DV79
DivK1c_000655
EINECS 214-818-2
Emorhalt
Exacyl
Frenolyse
HMS1568D03
HMS1921F08
HMS2092P03
HMS502A17
Hexapromin
Hexatron
I04-0993
IDI1_000655
KABI 2161
KBio1_000655
KBio2_001871
KBio2_004439
KBio2_007007
KBio3_002337
KBioGR_000511
 
KBioSS_001871
LS-56611
LS-56612
LT00159441
Mastop
MolPort-001-792-390
MolPort-002-512-008
NCGC00016569-01
NCGC00016569-02
NCGC00016569-03
NCGC00094944-01
NCGC00094944-02
NINDS_000655
NSC 291305
NSC291305
Oprea1_786414
Prestwick0_000171
Prestwick1_000171
Prestwick2_000171
Prestwick3_000171
Prestwick_476
RP 18,429
Rikavarin
Rikavarin (TN)
Rikavarin-S
SPBio_000689
SPBio_001982
SPECTRUM1502026
STK503668
STOCK1N-16183
Spectrum2_000655
Spectrum3_001189
Spectrum4_000046
Spectrum5_001258
Spectrum_001391
Spiramin
Tamcha
Tranex
Tranexamate
Tranexamic acid (JP15/USAN/INN)
Tranexamic acid [USAN:INN:BAN:JAN]
Tranexamic acid cis-form
Tranexamsaeure
Tranexan
Tranexmic acid
Tranhexamic acid
Trans AMCHA
Trans-1-(Aminomethyl)cyclohexane-4-carboxylic acid
Trans-4-(Aminomethyl)-1-cyclohexanecarboxylic acid
Trans-p-(Aminomethyl)cyclohexanecarboxylic
Transamin
Transamin (TN)
Transamlon
Trasamlon
UNII-6T84R30KC1
Ugurol
WLN: L6TJ AVQ D1Z -T
cis-4-(Aminomethyl)cyclohexanecarboxylic acid
cis-4-Aminomethylcyclohexane-1-carboxylic acid
cis-AMCHA
t-AMCHA
tranexamic acid
tranexmic acid
trans-1-Aminomethylcyclohexane-4-carboxylic acid
trans-4-(Aminomethyl)cyclohexane-1-carboxylic acid
trans-4-(Aminomethyl)cyclohexane-carboxylic acid
trans-4-(Aminomethyl)cyclohexanecarboxylic acid
trans-4-(Aminomethyl)cyclohexanecarboxylic acid ester
trans-4-Aminomethylcyclohexane-1-carboxylic acid
trans-4-aminomethylcyclohexane-1-carboxylic acid
trans-Amcha
trans-Tranexamic acid
trans-p-(Aminomethyl)cyclohexanecarboxylic acid
21
Folic Acidapproved, nutraceutical, vet_approvedPhase 2, Phase 3439259-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
22
leucovorinapproved, NutraceuticalPhase 2, Phase 3323558-05-954575, 6560146, 143
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formyltetrahydrofolic acid
Acide folinique
Calcium citrovorum factor
Calcium folinate
Citrovorum factor
Folinate
Folinic acid
Folinic acid calcium salt
 
Folinic acid calcium salt USP27
Folinic acid-SF
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
L-Leucovorin
L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid
L-leucovorin
Leucal
Leucovorin calcium
Leucovorin folinic acid
Leucovorinum
Leukovorin
Levoleucovorin
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyl-THF
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Welcovorin
Wellcovorin
folinate
23
Myrrhapproved, NutraceuticalPhase 319000-45-7
Synonyms:
Bola resin
Commiphora molmol resin
Commiphora myrrha gum resin
Commiphora myrrha resin
Commiphora myrrha resin extract
Common myrrh
Hirabol myrrh
 
Mo yao
Moyao (commiphora molmol)
Moyao (commiphora myrrha)
Myrrh (commiphora molmol)
Myrrh (commiphora myrrha)
Myrrha
Myrrha (commiphora molmol)
Myrrha (commiphora myrrha)
24VitaminsPhase 35282
25MicronutrientsPhase 36001
26Trace ElementsPhase 36001
27TriclabendazolePhase 32
28VaccinesPhase 3, Phase 2, Phase 16611
29Vitamin B ComplexPhase 2, Phase 34337
30Folic Acid AntagonistsPhase 2, Phase 32257
31Renal AgentsPhase 2, Phase 3754
32SulfalenePhase 2, Phase 384
33Fanasil, pyrimethamine drug combinationPhase 3, Phase 2122
34
PiperaquinePhase 31094085-31-85079497
Synonyms:
1,3-bis(1-(7-chloro-4'-quinolyl)-4'-piperazinyl)propane
1,3-bis(4-(7'-chloro-4'-quinoline)-1-piperazine)
4,4'-(propane-1,3-diyldipiperazine-4,1-diyl)bis(7-chloroquinoline)
4085-31-8
5-23-03-00072 (Beilstein Handbook Reference)
7-chloro-4-[4-[3-[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propyl]piperazin-1-yl]quinoline
83764-65-2
AC1L3UA1
AC1Q3T7B
AR-1F7471
 
BRN 0905079
C29H32Cl2N6
CHEMBL303933
CID122262
FT-0082661
I06-1673
LS-142194
Piperaquinoline
Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro- (9CI)
Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-)
ST51053186
piperaquine
35CoagulantsPhase 31500
36Antifibrinolytic AgentsPhase 3484
37HemostaticsPhase 31443
38HematinicsPhase 31684
39Ferric CompoundsPhase 3194
40FolateNutraceuticalPhase 2, Phase 34392
41Vitamin B9NutraceuticalPhase 2, Phase 34392
42Iron SupplementNutraceuticalPhase 3180
43
MefloquineapprovedPhase 25753230-10-74046
Synonyms:
(+)-(11R,2'S)-erythro-Mefloquine
(+)-Mefloquine
(+)-Threo-Mefloquine
(-)-(11S,2'R)-erythro-Mefloquine
(-)-Mefloquine
(-)-Threo-Mefloquine
(DL-erythro-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol
(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol
(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol
(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol
(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol
(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2R)-piperidin-2-yl]methanol
49752-90-1
51688-68-7
51742-87-1
51744-84-4
51744-85-5
53230-10-7
68682-27-9
AB00052310
AC1L1HAJ
AC1L249S
AC1L9UO6
AC1MHD7J
AC1MHD7O
AC1Q4K1I
AR-1G4597
BIDD:GT0596
BIDD:PXR0166
BPBio1_000190
BRD-A89585551-003-03-4
BSPBio_000172
C07633
C17H16F6N2O
CAS-51773-92-3
CHEBI:151162
CHEBI:403542
CHEMBL411329
CHEMBL411685
CHEMBL411686
CHEMBL416956
CID3000506
CID3000516
CID4046
CID40692
CID456309
D04895
DB00358
DivK1c_000790
EINECS 256-468-3
Erthro-.alpha.-[2-piperidyl]-2,8-bis[trifluoromethyl]-4-quinolinemethanol
HMS1922C09
HMS502H12
HSDB 6853
IDI1_000790
KBio1_000790
KBio2_001792
KBio2_004360
KBio2_006928
KBio3_002046
KBioGR_001392
KBioSS_001792
LS-142023
 
LS-187797
Lariam
Lariam (Hydrochloride)
MQ
Mefloquin
Mefloquina
Mefloquina [INN-Spanish]
Mefloquine
Mefloquine (USAN/INN)
Mefloquine HCL
Mefloquine [USAN:INN:BAN]
Mefloquine aziridine
Mefloquinone
Mefloquinum
Mefloquinum [INN-Latin]
Mephloquine
MolPort-003-981-155
Méfloquine
NCGC00016864-01
NCGC00094994-01
NCGC00094994-02
NCGC00094994-03
NCGC00094994-04
NCGC00161831-01
NCGC00161831-02
NINDS_000790
NSC157387
Prestwick0_000126
Prestwick1_000126
Prestwick2_000126
Prestwick3_000126
RO 13-7224
RO 13-7225
RTI1169-1-1
RTI1172-1-1
RTI1173-1-1
RTI1174-1-1
RTI1188-1-1
RTI1189-1-1
Racemic mefloquine
Ro 21-5998
Ro 21-5998 (Hydrochloride)
Ro 215998
Ro-21-5998-001
SPB-80406
SPBio_001591
SPBio_002111
SPECTRUM1503070
Spectrum2_001516
Spectrum3_000953
Spectrum4_001066
Spectrum5_001122
Spectrum_001312
UNII-TML814419R
WR 142490
WR-142,490
WR-142490
WR-177,602
[(R*,S*)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol
[2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol
alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol
alpha-2-Piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol
mefloquine
nchembio.215-comp3
nchembio.87-comp20
44Pharmaceutical SolutionsPhase 28192
45
Aluminum hydroxideapprovedPhase 121021645-51-2
Synonyms:
Al(OH)3
Aluminium hydroxide
Aluminium hydroxide gel, dried
 
Aluminium hydroxide, dried
Aluminum hydroxide gel, dried
Aluminum hydroxide, dried
Dried aluminium hydroxide
Dried aluminum hydroxide gel
46Gastrointestinal AgentsPhase 18402
47ImmunoglobulinsPhase 16394
48Anti-Ulcer AgentsPhase 11842
49Aluminum sulfatePhase 192
50Adjuvants, ImmunologicPhase 12554

Interventional clinical trials:

(show top 50)    (show all 61)
idNameStatusNCT IDPhase
1Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, GhanaUnknown statusNCT01459146Phase 4
2Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital ImmunologyCompletedNCT02878564Phase 4
3Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in BrazilCompletedNCT00403611Phase 4
4A Multinational Trial of the Efficacy of Albendazole Against Soil-transmitted Nematode Infections in ChildrenCompletedNCT01087099Phase 4
5Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST)Not yet recruitingNCT02868385Phase 4
6Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With SchistosomiasisNot yet recruitingNCT02734186Phase 4
7Safety and Efficacy of Mirazid for Schistosomiasis TreatmentCompletedNCT01529710Phase 3
8Efficacy of Bilhvax in Association With Praziquantel for Prevention of Clinical Recurrences of Schistosoma HaematobiumCompletedNCT00870649Phase 3
9Schistosoma Haematobium Infections and PraziquantelCompletedNCT01558336Phase 3
10Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating SchistosomiasisCompletedNCT00510159Phase 2, Phase 3
11Impact IPT With Sulfadoxine-pyrimethamine or Sulfadoxine-pyrimethamine Plus Piperaquine in SchoolchildrenCompletedNCT01722539Phase 3
12The Chinese-made Praziquantel for Treatment of Schistosoma HaematobiumRecruitingNCT03133832Phase 3
13Haemorrhage Alleviation With Tranexamic Acid- Intestinal SystemRecruitingNCT01658124Phase 3
14IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in TanzaniaActive, not recruitingNCT02541708Phase 3
15Activity of Mefloquine Against Urinary SchistosomiasisCompletedNCT01132248Phase 2
16Schistosoma Mansoni Morbidity in Children Aged 1-5 YearsCompletedNCT01901484Phase 2
17S. Japonicum and Pregnancy OutcomesCompletedNCT00486863Phase 2
18Trial to Investigate the Effect of Schistosoma Mansoni Infection on the Response to Vaccination With MVA85A in BCG-vaccinated African AdolescentsCompletedNCT02178748Phase 2
19An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni)RecruitingNCT02806232Phase 2
20Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic RegionsActive, not recruitingNCT03041766Phase 2
21Study to Evaluate the Safety of the Vaccine Prepared sm14 Against SchistosomiasisCompletedNCT01154049Phase 1
22Clinical Trial of Bilhvax,a Vaccine Candidate Against SchistosomiasisCompletedNCT01512277Phase 1
23Praziquantel-Pharmacokinetic StudyCompletedNCT01288872Phase 1
24Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDSCompletedNCT02376582Phase 1
25A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy AdultsActive, not recruitingNCT02337855Phase 1
26A Phase Ib Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Exposed AdultsNot yet recruitingNCT03110757Phase 1
27Evaluation of Strategies for Improved Uptake of Preventive Treatment for Intestinal SchistosomiasisUnknown statusNCT01869465
28Antioxidant Supplements in the Reversal of Schistosomal Peri-portal FibrosisUnknown statusNCT01260012
29A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment OutcomesUnknown statusNCT01541631
30Health Benefits of Repeated Treatment in Pediatric SchistosomiasisCompletedNCT01424410
31Women and Children as the Focus for Control of Schistosomiasis Infections in the Irrigations Area of Burkina FasoCompletedNCT00463528
32Arachidonic Acid Treatment Against Schistosomiasis Infection in ChildrenCompletedNCT02144389
33Urinary Schistosomiasis InfectionCompletedNCT00138450
34Assessment of Anaemia Attributable to Schistosomiasis in School Children in Kenya: Mechanisms and Effect of TreatmentCompletedNCT00414479
35Schistosomiasis in Women of Reproductive Age in Burkina Faso: Implications for ControlCompletedNCT00463632
36Iron Supplementation in Schistosomiasis and Soil Transmitted Helminths Control Programmes in ZambiaCompletedNCT00276224
37Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control ProgrammesCompletedNCT00463593
38Using Community-Based Volunteers to Reach Non-Enrolled School Aged Children Through Community-Directed Treatment of Schistosomiasis in School-Aged Children in Rural Northern GhanaCompletedNCT00463931
39Evaluation of the Use of a Urin Test Strip to Determine the Spread of Schistosoma Infections in Areas Where Schistosomiasis Infections Are Low in KenyaCompletedNCT00463307
40Urogenital Schistosomiasis and Sexually Transmitted Infections in MadagascarCompletedNCT00713999
41Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern SenegalCompletedNCT01553552
42Treatment Schistosomal Portal Hypertension: Efficacy of Endoscopy or SurgeryCompletedNCT01931826
43The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, UgandaCompletedNCT00215267
44Safety and Efficacy of Drug Combinations Against SchistosomiasisCompletedNCT01050374
45Worm Infestation and Child Health in ZimbabweCompletedNCT01283165
46Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen RepertoiresCompletedNCT01214876
47Pulmonary Hypertension in Patients With Sickle Cell Disease in NigeriaCompletedNCT00367523
48Safety and Efficacy of Drug Combinations Against Triple InfectionsCompletedNCT01050517
49Community Directed Treatment of Soil-Transmitted Helminths Among Young Children in ZambiaCompletedNCT00349323
50Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, TanzaniaCompletedNCT00347113

Search NIH Clinical Center for Schistosomiasis

Inferred drug relations via UMLS68/NDF-RT46:

Genetic Tests for Schistosomiasis

About this section

Anatomical Context for Schistosomiasis

About this section

MalaCards organs/tissues related to Schistosomiasis:

36
Liver, Skin, Spleen, Kidney, Testes, Lung, Colon

Publications for Schistosomiasis

About this section

Articles related to Schistosomiasis:

(show top 50)    (show all 1303)
idTitleAuthorsYear
1
New index for the diagnosis of liver fibrosis in Schistosomiasis mansoni. (28079240)
2017
2
Towards interruption of schistosomiasis transmission in sub-Saharan Africa: developing an appropriate environmental surveillance framework to guide and to support 'end game' interventions. (28088239)
2017
3
Indicators of improved water access in the context of schistosomiasis transmission in rural Eastern Region, Ghana. (27939198)
2017
4
A new global strategy for the elimination of schistosomiasis. (27939558)
2017
5
Exploring possibilities for an alternative approach in experimental schistosomiasis mansoni: the peritoneal cavity of mice. (28030359)
2017
6
Recent advances in proteomic applications for schistosomiasis research: potential clinical impact. (27937063)
2017
7
Urogenital schistosomiasis during pregnancy is associated with low birth weight delivery: analysis of a prospective cohort of pregnant women and their offspring in Gabon. (28003151)
2017
8
Cerebral schistosomiasis: diffusion-weighted imaging helps to differentiate from brain glioma and metastasis. (28090792)
2017
9
Estrogen catechols detection as biomarkers in schistosomiasis induced cancer and infertility. (28018158)
2017
10
Schistosomiasis and Soil Transmitted Helminths Distribution in Benin: A Baseline Prevalence Survey in 30 Districts. (27643795)
2016
11
Human Schistosomiasis mansoni associated with hepatocellular carcinoma in Egypt: current perspective. (27605822)
2016
12
POTENTIAL CONTRIBUTION OF ADULT POPULATIONS TO THE MAINTENANCE OF SCHISTOSOMIASIS AND SOIL-TRANSMITTED HELMINTH INFECTIONS IN THE SIAVONGA AND MAZABUKA DISTRICTS OF ZAMBIA. (27180827)
2016
13
Magnetic Resonance Spectroscopy for Evaluating Portal-Systemic Encephalopathy in Patients with Chronic Hepatic Schistosomiasis Japonicum. (27977668)
2016
14
Evaluation of schistosomiasis control activities in the Family Health Strategy in municipalities in the Jequitinhonha Valley, Minas Gerais, Brazil. (27532760)
2016
15
Saposin-like Proteins, a Multigene Family of Schistosoma Species, Are Biomarkers for the Immunodiagnosis of Schistosomiasis Japonica. (27190177)
2016
16
Intestinal Schistosomiasis among Primary Schoolchildren in Two On-Shore Communities in Rorya District, Northwestern Tanzania: Prevalence, Intensity of Infection and Associated Risk Factors. (27822385)
2016
17
Significance of Echogenic Snow Sign as an Ultrasonography Finding for Diagnosis of Urogenital Schistosomiasis. (27549638)
2016
18
Circulating cathodic antigen cassette test versus haematuria strip test in diagnosis of urinary schistosomiasis. (27876913)
2016
19
Policy Support and Resources Mobilization for the National Schistosomiasis Control Programme in The People's Republic of China. (27137452)
2016
20
Improving the understanding of schistosomiasis among adolescents in endemic areas in Brazil: A comparison of educational methods. (27180618)
2016
21
Smallpox and Dracunculiasis: The Scientific Value of Infectious Diseases That Have Been Eradicated or Targeted for Eradication. Is Schistosomiasis Next? (26741130)
2016
22
Development and Application of Diagnostics in the National Schistosomiasis Control Programme in The People's Republic of China. (27137454)
2016
23
Protection and immunological study on two tetraspanin-derived vaccine candidates against schistosomiasis japonicum. (27189226)
2016
24
The Accuracy of Praziquantel Dose Poles for Mass Treatment of Schistosomiasis in School Girls in KwaZulu-Natal, South Africa. (27139497)
2016
25
Towards the Elimination of Schistosomiasis japonica through Control of the Disease in Domestic Animals in The People's Republic of China: A Tale of over 60Years. (27137450)
2016
26
Experiences and perspectives of community health workers from implementing treatment for schistosomiasis using the community directed intervention strategy in an informal settlement in Kisumu City, western Kenya. (27634152)
2016
27
Multi-host model and threshold of intermediate host Oncomelania snail density for eliminating schistosomiasis transmission in China. (27535177)
2016
28
Cervical cytology as a diagnostic tool for female genital schistosomiasis: Correlation to cervical atypia and Schistosoma polymerase chain reaction. (27168759)
2016
29
Receptor Antagonist of IL-13 Exerts a Potential Negative Regulation During Early Infection of Human Schistosomiasis. (27507682)
2016
30
Diagnostic Tests to Support Late-Stage Control Programs for Schistosomiasis and Soil-Transmitted Helminthiases. (28005900)
2016
31
LOW PREVALENCE OF INTESTINAL SCHISTOSOMIASIS AMONG FISHERFOLK LIVING ALONG THE RIVER NILE IN NORTH-WESTERN UGANDA: A BIOSOCIAL INVESTIGATION. (27428067)
2016
32
Health Education as an Important Component in the National Schistosomiasis Control Programme in The People's Republic of China. (27137451)
2016
33
Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis. (27658198)
2016
34
Toxoplasma gondii GRA15II effector-induced M1 cells ameliorate liver fibrosis in mice infected with Schistosomiasis japonica. (27157496)
2016
35
Hydrology and density feedbacks control the ecology of intermediate hosts of schistosomiasis across habitats in seasonal climates. (27162339)
2016
36
Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy. (27507822)
2016
37
Decline in transmission of schistosomiasis mansoni in Oman. (27955687)
2016
38
Acute abdomen and schistosomiasis: A letter to the editor. (27531682)
2016
39
Schistosomiasis transmission in Europe. (27197550)
2016
40
Estrogen metabolites for the diagnosis of schistosomiasis associated urinary bladder cancer. (27014746)
2016
41
An extensive burden of giardiasis associated with intestinal schistosomiasis and anaemia in school children on the shoreline of Lake Albert, Uganda. (27864517)
2016
42
Factors influencing community participation in control and related operational research for urogenital schistosomiasis and soil-transmitted helminths in rural villages of Kwale County, coastal Kenya. (27642474)
2016
43
Non-necrotizing colonic granuloma induced by schistosomiasis. (27987283)
2016
44
Evaluation of Lethal Giant Larvae as a Schistosomiasis Vaccine Candidate. (27957496)
2016
45
Urogenital schistosomiasis transmission on Unguja Island, Zanzibar: characterisation of persistent hot-spots. (27986092)
2016
46
Treatment of Schistosomiasis in a Patient Allergic to Praziquantel: A Praziquantel Desensitization and Treatment Protocol. (27573630)
2016
47
Knowledge and awareness of genital involvement and reproductive health consequences of urogenital schistosomiasis in endemic communities in Ghana: a cross-sectional study. (27655032)
2016
48
Outbreak of urogenital schistosomiasis in Corsica (France): an epidemiological case study. (27197551)
2016
49
Assessment of schistosomiasis in the semi-arid Northeast region of Brazil: the SALo Francisco River large-scale water transposition project. (27192599)
2016
50
Praziquantel for schistosomiasis in pregnancy. (27599647)
2016

Variations for Schistosomiasis

About this section

Expression for genes affiliated with Schistosomiasis

About this section
Search GEO for disease gene expression data for Schistosomiasis.

Pathways for genes affiliated with Schistosomiasis

About this section

Pathways related to Schistosomiasis according to GeneCards Suite gene sharing:

(show top 50)    (show all 56)
idSuper pathwaysScoreTop Affiliating Genes
19.9IL13, IL4, IL5
29.7IFNG, IL10, TNF
39.7IFNG, IL13, IL2
4
Show member pathways
9.7IFNG, IFNGR1, TNF
5
Show member pathways
9.6IFNG, IL2, TNF
69.6IFNG, IL2, TNF
79.6IFNG, IL2, TNF
89.6IL13, IL4, IL5, TNF
99.6IL10, IL13, IL4, TNF
109.5CD40LG, IFNG, IL10, TNF
11
Show member pathways
9.5IFNG, IFNGR1, IL4, TNF
129.5GAPDH, IL10, IL13, TNF
139.5IFNG, IFNGR1, IL10, TNF
14
Show member pathways
9.4IFNG, IL10, IL2, TNF
159.4IFNG, IL10, IL2, TNF
16
Show member pathways
9.4CD40LG, IFNG, IL2, TNF
179.4CD40LG, IL10, IL4, IL5, TNF
18
Show member pathways
9.4IFNG, IL13, IL4, IL5, TNF
199.4IFNG, IL13, IL4, IL5, TNF
209.3IFNG, IL13, IL2, IL4, IL5
21
Show member pathways
9.3IFNG, IL2, IL4, STAT6
229.3CD40LG, IFNG, IL2, IL4, IL5
239.2ARG1, IFNG, IL10, TNF
24
Show member pathways
9.2IFNG, IFNGR1, IL2, IL4, TNF
25
Show member pathways
9.1IFNG, IFNGR1, IL10, IL2, TNF
269.1IFNG, IL10, IL13, IL2, IL4, IL5
27
Show member pathways
9.1CD40LG, IFNG, IFNGR1, IL10, IL4, TNF
289.0IFNG, IFNGR1, IL10, IL2, STAT6
29
Show member pathways
9.0CD40LG, IFNG, IL2, IL4, IL5, TNF
30
Show member pathways
9.0IFNG, IFNGR1, IL13, IL2, IL4, TNF
318.9ARG1, IFNG, IL2, IL4, TNF
32
Show member pathways
8.8CD40LG, IL10, IL13, IL2, IL4, IL5
338.8CD40LG, IL10, IL13, IL2, IL4, IL5
34
Show member pathways
8.8IFNG, IL10, IL13, IL2, IL4, IL5
358.8IFNG, IL10, IL13, IL2, IL4, IL5
368.8IFNG, IL10, IL13, IL2, IL4, IL5
37
Show member pathways
8.8CD40LG, IFNG, IL10, IL2, IL4, IL5
38
Show member pathways
8.7IFNG, IFNGR1, IL10, IL2, STAT6, TNF
398.7CD79A, IFNG, IL10, IL2, IL4, IL5
408.7IFNG, IL10, IL13, IL2, IL4, IL5
41
Show member pathways
8.6ALB, F2, IFNG, IL2, IL4, TNF
42
Show member pathways
8.5F2, IFNG, IL10, IL2, STAT6, TNF
43
Show member pathways
8.5CD79A, IGHE, IL13, IL4, IL5, TNF
44
Show member pathways
8.5CD79A, IFNG, IFNGR1, IL2, IL4, STAT6
45
Show member pathways
8.4IFNG, IFNGR1, IL10, IL13, IL2, IL4
46
Show member pathways
8.4CD40LG, IL10, IL13, IL2, IL4, IL5
478.3IGHE, IL10, IL13, IL4, STAT6, TNF
488.3CD40LG, CD79A, IFNG, IL10, IL2, IL4
49
Show member pathways
8.1IFNG, IFNGR1, IL10, IL13, IL2, IL4
507.9ARG1, CD40LG, IGHE, IL10, IL4, IL5

GO Terms for genes affiliated with Schistosomiasis

About this section

Cellular components related to Schistosomiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1blood microparticleGO:00725629.3ALB, F2, IGHE, SERPINF2
2external side of plasma membraneGO:00098978.5CD40LG, CD79A, F2, IFNG, IGHE, IL13
3extracellular spaceGO:00056156.7ALB, ARG1, CD40LG, F2, IFNG, IL10
4extracellular regionGO:00055766.6ALB, ARG1, CD40LG, F2, IFNG, IGHE

Biological processes related to Schistosomiasis according to GeneCards Suite gene sharing:

(show all 37)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of complement-dependent cytotoxicityGO:190366010.8IL13, IL4
2positive regulation of immunoglobulin productionGO:000263910.8IL13, IL4
3positive regulation of mast cell degranulationGO:004330610.8IL13, IL4
4endothelial cell apoptotic processGO:007257710.7IL10, TNF
5positive regulation of mononuclear cell migrationGO:007167710.7IL4, TNF
6negative regulation of cytokine secretion involved in immune responseGO:000274010.7IL10, TNF
7negative regulation of T-helper 17 cell differentiationGO:200032010.7IL2, IL4
8positive regulation of calcidiol 1-monooxygenase activityGO:006055910.7IFNG, TNF
9negative regulation of endothelial cell apoptotic processGO:200035210.6IL10, IL13, IL4
10positive regulation of isotype switching to IgE isotypesGO:004829510.6IL4, STAT6
11defense response to protozoanGO:004283210.6IFNG, IL10, IL4
12positive regulation of MHC class II biosynthetic processGO:004534810.6IFNG, IL10, IL4
13B cell proliferationGO:004210010.5CD40LG, CD79A, IL10
14positive regulation of chemokine biosynthetic processGO:004508010.5IFNG, IL4, TNF
15negative regulation of growth of symbiont in hostGO:004413010.5IFNG, IL10, TNF
16positive regulation of isotype switching to IgG isotypesGO:004830410.4IFNG, IL2, IL4
17negative regulation of fibrinolysisGO:005191810.4F2, SERPINF2
18positive regulation of cytokine secretionGO:005071510.4GAPDH, IL10, TNF
19positive regulation of smooth muscle cell proliferationGO:004866110.4IL13, SERPINF2, TNF
20regulation of isotype switchingGO:004519110.3IL10, IL4
21B cell differentiationGO:003018310.3CD40LG, CD79A, IL10, IL4
22receptor biosynthetic processGO:003280010.3IL10, TNF
23positive regulation of vitamin D biosynthetic processGO:006055710.3IFNG, TNF
24positive regulation of sequence-specific DNA binding transcription factor activityGO:005109110.3IL10, IL4, IL5, TNF
25regulation of proton transportGO:001015510.3IL13, IL4
26positive regulation of B cell proliferationGO:003089010.3IL13, IL2, IL4, IL5
27regulation of immunoglobulin secretionGO:005102310.3CD40LG, TNF
28positive regulation of T cell proliferationGO:004210210.2CD40LG, IFNG, IL2, IL4
29positive regulation of tyrosine phosphorylation of STAT proteinGO:004253110.1IFNG, IL2, IL4
30type 2 immune responseGO:004209210.1IL10, IL4
31inflammatory responseGO:000695410.1CD40LG, IL10, IL13, IL5, TNF
32T-helper 1 cell lineage commitmentGO:000229610.0IL4, STAT6
33cellular response to lipopolysaccharideGO:007122210.0ARG1, IFNG, IL10, TNF
34positive regulation of protein phosphorylationGO:00019349.7F2, IFNG, IL2, IL4, TNF
35defense response to bacteriumGO:00427429.4IFNG, IGHE, IL10, RNASE3, TNF
36positive regulation of transcription from RNA polymerase II promoterGO:00459449.0IFNG, IL10, IL2, IL4, SERPINF2, STAT6
37immune responseGO:00069558.5CD40LG, IFNG, IGHE, IL10, IL13, IL2

Molecular functions related to Schistosomiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytokine activityGO:00051259.2CD40LG, IFNG, IL10, IL13, IL2, IL4
2growth factor activityGO:00080839.1F2, IL10, IL2, IL4, IL5

Sources for Schistosomiasis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet